Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

BACKGROUND: Activated PI3K-AKT pathway may contribute to decrease sensitivity to inhibitors of key pathogenetic effectors (mutated BRAF, active NRAS or MEK) in melanoma. Functional alterations are deeply involved in PI3K-AKT activation, with a minimal role reported for mutations in PIK3CA, the catal...

Descripción completa

Detalles Bibliográficos
Autores principales: Manca, Antonella, Lissia, Amelia, Capone, Mariaelena, Ascierto, Paolo A, Botti, Gerardo, Caracò, Corrado, Stanganelli, Ignazio, Colombino, Maria, Sini, MariaCristina, Cossu, Antonio, Palmieri, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312444/
https://www.ncbi.nlm.nih.gov/pubmed/25627962
http://dx.doi.org/10.1186/s12967-015-0401-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312444/
https://www.ncbi.nlm.nih.gov/pubmed/25627962
http://dx.doi.org/10.1186/s12967-015-0401-8

Ejemplares similares